Le Lézard
Classified in: Science and technology, Business
Subjects: FNC, PDT, VEN

Crypto Derivatives Exchange ACDX Closes $10M Investment Rounds, Launches Platform & Uniswap Sale Today

Founded by the Ex-OKEx COO Andy Cheung, ACDX is offering futures, perpetual, and spread trading at launch

MAHE, Seychelles, Sept. 29, 2020 /PRNewswire/ --  ACDX, Advanced Crypto Derivatives Exchange, launched its public beta today and announced that it has raised US$10 million in series pre-A equity and token private investment rounds that valued the exchange at US$33.3 million (post-money). The two financing rounds are led by the community-driven VC firm VYSYN VENTURES.

Soon after closing the private rounds, ACDX announced its convertible token sale on Uniswap. With the ticker cACXT, convertible ACXT can be later converted to ACXT, the native governance token of the exchange. Starting at an initial price of US$1.25 and a supply of 400,000 tokens, convertible ACXT can be purchased by anyone on the decentralized platform. At the time of writing, cACXT is trading at US$3.8.

Another public token sale is expected to commence in Nov 2020 on ACDX. The sale price will be determined based on the last trading price of cACXT on Uniswap, and the supply will be 250,000 tokens only.

After concluding the public sales, ACDX will initiate the planned US$30M series-A funding round.

At launch, ACDX is offering quarterly futures, perpetual futures, and futures spread trading. Among the offerings, futures spread trading is the first innovative product that ACDX releases to the market.

Futures spread is a popular derivative in the traditional market. It provides the benefits of lower margin requirements and risks. With the mission of bringing more innovations and transparency to the cryptocurrency industry, ACDX also has a series of new products in the 2020 pipeline.

"On the contrary to many projects out there, the funding rounds are largely driven by the community. This concurs with the idea of our governance token ACXT. Despite DeFi taking the spotlight in cryptocurrency this year, derivatives still have a massive potential. If you compare crypto derivatives with the traditional market, you will see the huge opportunities ACDX is exploiting," said Andy Cheung, founder and executive chairman of ACDX.

About ACDX

ACDX offers a next-generation cryptocurrency derivatives trading platform with cryptocurrency structured products that the industry has not yet seen. The exchange is focused on true innovation across a wide range of easy-to-use, fair, and transparent trading products that suit the needs of current and emerging cryptocurrency traders.

Media Contact

Jesper Cheng
Tel: +852-9019-3789
Email: jesper@acdx.io

These press releases may also interest you

at 08:00
On the cusp of its sixth anniversary, Empower Retirement, the nation's second-largest retirement services provider,1 is announcing record sales growth and new client commitments totaling some $110 billion while furthering plans for expanded offerings...

at 08:00
Accenture and Springboard Enterprises are celebrating "Women Transforming Industries" and the organization's 20th anniversary by honoring four women CEOs in the retail and health industries for their technological innovation. The honorees are:...

at 07:47
ADP, a leading global technology company providing human capital management (HCM) solutions, today announced winners of several awards presented to key partners at the third annual ADP Marketplace Partner Summit. Held virtually this year, the event...

at 07:45
CalAmp , a global technology solutions pioneer transforming the mobile connected economy, today announced a contract renewal with a Louisiana municipality charged with protecting its community from the dangers of disease-bearing mosquitoes and...

at 07:35
Lantheus Holdings, Inc. (the "Company") today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, November 5, 2020, to discuss its financial and operating results for the third quarter of 2020. To access the live...

at 07:35
Navidea Biopharmaceuticals, Inc. ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced that members of management will participate in the Virtual Investor KOL...

News published on 29 september 2020 at 02:08 and distributed by: